Publications:

Advanced lung adenocarcinoma (LUAD) patient with EGFR mutations benefited from multiline combination targeted therapies after osimertinib (AZD9291) resistance: a case report.

Translational Cancer Research

Chen, Jingyu J; Zhao, Xueqi X; Wang, Jinlin J; Liu, Fangfang F; Zhang, Linli L; Chen, Yuan Y; Chu, Qian Q

Publication Date: 2022-09

Variant appearance in text: EGFR: L799Q

PubMed Link: 36237272

Variant Present in the following documents:

• Main text
• tcr-11-09-3343-prf.pdf
• tcr-11-09-3343.pdf

View BVdb publication page

Epidermal growth factor receptor somatic mutation analysis in 354 Chinese patients with non-small cell lung cancer.

Oncology Letters

Quan, Xueping X; Gao, Hongjun H; Wang, Zhikuan Z; Li, Jie J; Zhao, Wentao W; Liang, Wei W; Yu, Qiang Q; Guo, Dongliang D; Hao, Zhanping Z; Liu, Jingxin J

Publication Date: 2018-02

Variant appearance in text: EGFR: L799Q

PubMed Link: 29434916

Variant Present in the following documents:

• Main text

View BVdb publication page